Alert detail
LCD L38974: MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer — Noridian
What changed
New LCD impacts billing for inherited cancer tests, effective 04/2024.
Who’s affected: Oncology billing teams · Effective: April 18, 2024
Affected codes
Primary source: View the official CMS/MAC document ↗
Get the action steps and full analysis
This change affects 47 billing codes.
The full analysis, the revision comparison and the as-of-date version of this policy are what a partner packet carries. The source document above is free and always will be.